InaKtif MGP (dp-ucMGP)
Product Description
An automated assay for the quantitative determination of the inactive dephosphorylated-uncarboxylated (dp-uc) isoform of Matrix Gla-Protein (MGP) in human plasma on the IDS-iSYS Multi-Discipline Automated System. Measurement of dp-ucMGP are used in the assessment of vitamin K status in the arterial vessel wall.
- Utilise conformation-specific monoclonal antibodies to ensure accurate dp-ucMGP circulating levels
- Correlated to the widely published lab-develop dp-ucMGP ELISA assay method
- Wide assay range suitable for Chronic Kidney Disease, Haemodialysis and Vitamin K Antagonist treated patients
- First fully automated CE marked IVD dp-ucMGP test for achieving fast and highly reproducible results for diagnostic and follow up of patients
-
- Price PA, Urist MR, Otawara Y: Matrix Gla protein, a new gammacarboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983, 117:765–771.
- Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewé RB et al. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost. 2010; 104: 811–822.
- Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost. 2007; 5: 2503–2511.
- Murshed M, Schinke T, McKee MD et al. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004; 165:625-630.
- Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008; 100: 593–603.
- Product Code: IS-4700 / IS-4730
- Number of Tests: 100
- Sample Type: Plasma
- Sample Volume: 50 µL plus dead volume
- Assay Range: 300 – 12,000 pmol/L
- Add to Enquiry Basket
Interested? Enquire now.
Add to Enquiry Basket
Related Products
| Assays | Certification | Platform | Clinical Area | Portfolio | RUO/IVD |
|---|---|---|---|---|---|
| 1,25-Dihydroxy Vitamin D | CE MarkedFDA Cleared | i10iSYS | CKD-MBDSarcoidosisVitamin D | Endocrinology | IVD |
| 1,25 VitDXp | CE Marked | iSYS | CKD-MBDVitamin D | Endocrinology | IVD |
| 25-Hydroxy Vitamin Dˢ EIA | CE MarkedFDA Cleared | Vitamin D | Endocrinology | IVD | |
| Intact PTH | CE MarkedFDA Cleared | i10iSYS | CKD-MBD | Endocrinology | IVD |
| Intact PINP | CE Marked | i10iSYS | Bone TurnoverCKD-MBD | Endocrinology | IVD |
| Ostase® BAP | CE MarkedFDA Cleared | i10iSYS | Bone TurnoverCKD-MBD | Endocrinology | IVD |